Notable examples include the development of Ebola and COVID-19 vaccines using adenoviral and other viral vector platforms. As the field of viral vector technology continues to evolve, several areas of ...

Today, Fuse Vectors announces $5.2 million in pre-seed financing led by HCVC to revolutionize gene therapy development with its cell-free viral vector technology. The funding will accelerate the ...

Both facilities specialise in viral vector development and manufacturing. A Thermo Fisher spokesperson told Pharmaceutical Technology: “In light of recent shifts in customer timelines and ...

CRISPR-based treatments are advancing, with the first U.S. approval granted in late 2023, paving the way for further innovation. Growing Pipeline of Viral Vector-based Therapies: Currently, 2,093 gene ...

Our other patented technology uses cell hybrids to increase production of antibodies and other proteins used in therapy. We hope to partner both our viral vector technology and protein production ...

Edinburgh-based biotech company Lentitek Ltd has secured £700,000 in private funding from Equity Gap, a leading Scottish angel investment syndicate, bringing its total investment to £1 million in the ...

Transgene’s programs utilize viral vector technology with the goal of indirectly or directly killing cancer cells. The Company’s clinical-stage programs consist of a portfolio of therapeutic vaccines ...